These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1507398)

  • 1. [General pharmacology of cefepime].
    Goto A; Amano M; Sakai A; Hara M; Takahashi N
    Jpn J Antibiot; 1992 Jun; 45(6):661-80. PubMed ID: 1507398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [General pharmacology of BMY-28100].
    Goto A; Amano M; Sakai A; Hara M; Takahashi N
    Jpn J Antibiot; 1990 Jul; 43(7):1289-309. PubMed ID: 2232158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cefepime (diHCl/L-arginine blend): intravenous continuous infusion and/or single dose subcutaneous toxicity study in rats and dogs].
    Kadota T; Kondoh H; Chikazawa H; Kuroyanagi K; Ishikawa K; Kawano S; Sakakura K; Takahashi N; Funahashi N; Shimizu N
    Jpn J Antibiot; 1992 Jun; 45(6):612-9. PubMed ID: 1507395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [General pharmacology of T-1982, a new cephamycin antibiotic].
    Takai A; Hirai S; Watanabe I; Hiraiwa T; Abe N; Arai H; Omori M; Tanada K; Senda N; Hashiba K; Matsukura K; Takata K; Okami H
    Jpn J Antibiot; 1982 Sep; 35(9):2139-54. PubMed ID: 7143714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [General pharmacology of T-2588, a new oral cephem antibiotic].
    Hirai S; Kodama T; Hiraiwa T; Abe N; Arai H; Ono S; Omori M; Nakada Y; Hashiba K; Tanada K
    Jpn J Antibiot; 1986 Apr; 39(4):958-78. PubMed ID: 3761550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [General pharmacology of T-3761, a new oral quinolone antibacterial agent (2). Effect on the respiratory and cardiovascular systems, autonomic nervous system and other functions].
    Furuhata K; Hiraiwa T; Terashima N; Arai H; Ono S; Hashiba K; Maekawa M; Kitamura K; Nakada Y; Mori Y
    Jpn J Antibiot; 1995 May; 48(5):706-32. PubMed ID: 7637205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General pharmacological properties of the new vasodilator flosequinan.
    Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reproductive and developmental toxicity studies on cefepime dihydrochloride administered subcutaneously to rats during the premating, gestation and lactation periods].
    Kai S; Kohmura H; Ishikawa K; Kawano S; Sakai A; Kuroyanagi K; Kadota T; Takahashi N
    Jpn J Antibiot; 1992 Jun; 45(6):642-60. PubMed ID: 1507397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.
    Furuta S; Shimada O; Doi N; Ukai K; Nakagawa T; Watanabe J; Imaizumi M
    Arzneimittelforschung; 2004; 54(12):868-80. PubMed ID: 15646371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General pharmacological profiles of the new beta-adrenoceptor antagonist carvedilol.
    Hirohashi M; Takasuna K; Tamura K; Yamaguchi K; Maekawa K; Yamada S; Iwasaki S; Yoshida M; Nomura M; Taguchi K
    Arzneimittelforschung; 1990 Jul; 40(7):735-46. PubMed ID: 1977393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General pharmacological properties of the main metabolite of flosequinan.
    Fujita S; Ikezono K; Umezato M; Hosoki E; Toba Y; Ishikawa M; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1212-22. PubMed ID: 1335257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [General pharmacology of T-3262, a new pyridonecarboxylic acid].
    Hirai S; Hiraiwa T; Arai H; Ono S; Tanaka K; Hashiba K; Nakada Y; Goden K; Tanada K; Maekawa M
    Jpn J Antibiot; 1989 Apr; 42(4):831-53. PubMed ID: 2769937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
    Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
    Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General pharmacological properties of the new angiotensin II receptor antagonist (+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate. Part I: Effects on central nervous system and other properties.
    Kito G; Morimoto S; Shiomi M
    Arzneimittelforschung; 1996 Jun; 46(6):572-9. PubMed ID: 8767346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General pharmacological properties of the potent angiotensin converting enzyme inhibitor rentiapril.
    Yamauchi H; Nishimura K; Nakata K; Suda H; Iso T; Shimizu M; Hiramatsu Y
    Arzneimittelforschung; 1987 Feb; 37(2):157-64. PubMed ID: 3034298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [General pharmacology of cefadroxil (author's transl)].
    Hasegawa Y; Muto N; Morita M
    Jpn J Antibiot; 1979 Dec; 32(12):1356-71. PubMed ID: 529420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General pharmacology of the new antiviral agent SK 1899.
    Ryu KH; Rhee HI; Jung I; Kim TS; Lee SJ; Im GJ; Lee N; Ryu DH; Kim YW; Kim JJ; Chang K; Lee BH; Shin HS; Kim EJ; Kim KH; Kim DK
    Arzneimittelforschung; 2000 Apr; 50(4):395-403. PubMed ID: 10800640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.